Hua Liu - Search Results

Year	Number of Results
2002	6
2003	5
2004	12
2005	32
2006	25
2007	32
2008	54
2009	47
2010	52
2011	65
2012	74
2013	84
2014	100
2015	99
2016	109
2017	130
2018	115
2019	125
2020	156
2021	61

1

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.

Chen Y, Peng C, Chen J, Chen D, Yang B, He B, Hu W, Zhang Y, Liu H, Dai L, Xie H, Zhou L, Wu J, Zheng S. Chen Y, et al. Among authors: liu h. Mol Cancer. 2019 Aug 22;18(1):127. doi: 10.1186/s12943-019-1053-8. Mol Cancer. 2019. PMID: 31438961 Free PMC article.

2

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

DiNardo CD, Stein EM, de Botton S, Roboz GJ, Altman JK, Mims AS, Swords R, Collins RH, Mannis GN, Pollyea DA, Donnellan W, Fathi AT, Pigneux A, Erba HP, Prince GT, Stein AS, Uy GL, Foran JM, Traer E, Stuart RK, Arellano ML, Slack JL, Sekeres MA, Willekens C, Choe S, Wang H, Zhang V, Yen KE, Kapsalis SM, Yang H, Dai D, Fan B, Goldwasser M, Liu H, Agresta S, Wu B, Attar EC, Tallman MS, Stone RM, Kantarjian HM. DiNardo CD, et al. Among authors: liu h. N Engl J Med. 2018 Jun 21;378(25):2386-2398. doi: 10.1056/NEJMoa1716984. Epub 2018 Jun 2. N Engl J Med. 2018. PMID: 29860938 Free article. Clinical Trial.

3

Single-Cell Profiles and Clinically Useful Properties of Human Mesenchymal Stem Cells of Adipose and Bone Marrow Origin.

Zhou W, Lin J, Zhao K, Jin K, He Q, Hu Y, Feng G, Cai Y, Xia C, Liu H, Shen W, Hu X, Ouyang H. Zhou W, et al. Among authors: liu h. Am J Sports Med. 2019 Jun;47(7):1722-1733. doi: 10.1177/0363546519848678. Epub 2019 May 17. Am J Sports Med. 2019. PMID: 31100005 Review.

4

p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation.

Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu HL, Yang C, Liu HF. Liu WJ, et al. Among authors: liu hf. Cell Mol Biol Lett. 2016 Dec 13;21:29. doi: 10.1186/s11658-016-0031-z. eCollection 2016. Cell Mol Biol Lett. 2016. PMID: 28536631 Free PMC article. Review.

5

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.

Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, Altman JK, Arellano ML, Donnellan W, Erba HP, Mannis GN, Pollyea DA, Stein AS, Uy GL, Watts JM, Fathi AT, Kantarjian HM, Tallman MS, Choe S, Dai D, Fan B, Wang H, Zhang V, Yen KE, Kapsalis SM, Hickman D, Liu H, Agresta SV, Wu B, Attar EC, Stone RM. Roboz GJ, et al. Among authors: liu h. Blood. 2020 Feb 13;135(7):463-471. doi: 10.1182/blood.2019002140. Blood. 2020. PMID: 31841594 Free PMC article. Clinical Trial.

6

Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix.

Wang Y, Yu D, Liu Z, Zhou F, Dai J, Wu B, Zhou J, Heng BC, Zou XH, Ouyang H, Liu H. Wang Y, et al. Among authors: liu h. Stem Cell Res Ther. 2017 Aug 14;8(1):189. doi: 10.1186/s13287-017-0632-0. Stem Cell Res Ther. 2017. PMID: 28807034 Free PMC article.

7

Effect of metformin treatment during pregnancy on women with PCOS: a systematic review and meta-analysis.

Tan X, Li S, Chang Y, Fang C, Liu H, Zhang X, Wang Y. Tan X, et al. Among authors: liu h. Clin Invest Med. 2016 Sep 11;39(4):E120-31. doi: 10.25011/cim.v39i4.27091. Clin Invest Med. 2016. PMID: 27619399 Review.

8

LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.

Liu H, Deng H, Zhao Y, Li C, Liang Y. Liu H, et al. J Exp Clin Cancer Res. 2018 Nov 21;37(1):279. doi: 10.1186/s13046-018-0950-9. J Exp Clin Cancer Res. 2018. PMID: 30463570 Free PMC article.

9

Integrated bioinformatics analysis of key genes involved in progress of colon cancer.

Yang H, Wu J, Zhang J, Yang Z, Jin W, Li Y, Jin L, Yin L, Liu H, Wang Z. Yang H, et al. Among authors: liu h. Mol Genet Genomic Med. 2019 Apr;7(4):e00588. doi: 10.1002/mgg3.588. Epub 2019 Feb 11. Mol Genet Genomic Med. 2019. PMID: 30746900 Free PMC article.

10

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.

Choe S, Wang H, DiNardo CD, Stein EM, de Botton S, Roboz GJ, Altman JK, Mims AS, Watts JM, Pollyea DA, Fathi AT, Tallman MS, Kantarjian HM, Stone RM, Quek L, Konteatis Z, Dang L, Nicolay B, Nejad P, Liu G, Zhang V, Liu H, Goldwasser M, Liu W, Marks K, Bowden C, Biller SA, Attar EC, Wu B. Choe S, et al. Among authors: liu h. Blood Adv. 2020 May 12;4(9):1894-1905. doi: 10.1182/bloodadvances.2020001503. Blood Adv. 2020. PMID: 32380538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results